Investor Presentation • Mar 7, 2024
Investor Presentation
Open in ViewerOpens in native device viewer
THIS PRESENTATION may contain forward looking statements. These statements are based on current expectations, estimates and projections of Envipco's management and information currently available to the company. Envipco cautions that such statements contain elements of risk and uncertainties that are difficult to predict and that could cause actual performance and position to differ materially from these statements. Envipco disclaims any obligation to update or revise any statements made in this presentation to reflect subsequent events or circumstances, except as required by law. Certain figures in this presentation, including financial data, have been rounded. Accordingly, figures shown for the same category presented in different tables may vary slightly and figures shown as totals in certain tables may not be an exact arithmetic aggregation of the figures which precede them.
Revenue generating country Preparations Commercial engagement Manufacturing facility
Sales office
Average Reverse Vending Machine price
EU Legislation driving deposit return schemes (DRS) in all EU countries
Strong Consumer push to address plastic pollution
Beverage brand holders needing clean feedstock to put back into new packaging
Industry acknowledgment that deposit return schemes work and serves the interest of all stakeholders
Threat avoidance on PET packaging bans
1) Key milestones taken from Council of the European Union position on Regulation of the European parliament and of the council on packaging and packaging waste, amending Regulation (EU) 2019/1020 and Directive (EU) 2019/904, and repealing Directive 94/62/EC, 18 December 2023 and pending final adoption.
Broad and proven product portfolio addressing all customer segments
Proven track record with world leading retailers showing our quality and commitment
Ample production capacity in USA, Germany and
Romania with the capacity to serve large Tier 1 retailers
Differentiating Envipco from our competitors
Osnabruck, Germany
Sebes, Romania
30,000
RVM production capacity per year
3,000
Quantum/Modula production capacity per year
| in EUR millions, unaudited | Q4 23 | Q4 22 | 2023 | 2022 |
|---|---|---|---|---|
| Revenues | 35.4 | 13.4 | 87.6 | 56.4 |
| - Europe |
28.0 | 4.6 | 55.5 | 18.1 |
| North America2 - |
7.5 | 8.7 | 32.1 | 38.2 |
| Gross Profit | 12.6 | 4.2 | 30.6 | 18.5 |
| Gross profit % | 35.5% | 31.2% | 35.0% | 32.8% |
| Operating Expenses | 8.8 | 6.5 | 28.4 | 23.1 |
| EBIT Net profit/(loss) after taxes |
4.23 | (2.3)1 | 2.73 | (2.7)1 |
| and minorities | 4.13 | (2.0)1 | 1.43 | (4.2)1 |
| EBITDA | 5.93 | (1.1)1 | 8.83 | 2.31 |
1) Including other income 2022 of EUR 2.0 million (PPP forgiveness).
2) Includes Rest of the World (RoW).
3) Includes other income of EUR 0.5m from resale of UK inventory
| in EUR millions, unaudited | Q4 23 | Q4 22 | 2023 | 2022 |
|---|---|---|---|---|
| Revenues | 35.4 | 13.4 | 87.6 | 56.4 |
| - Europe |
28.0 | 4.6 | 55.5 | 18.1 |
| North America2 - |
7.5 | 8.7 | 32.1 | 38.2 |
| Gross Profit | 12.6 | 4.2 | 30.6 | 18.5 |
| Gross profit % | 35.5% | 31.2% | 35.0% | 32.8% |
| Operating Expenses | 8-8 | 6.5 | 28.4 | 23.1 |
| EBIT Net profit/(loss) after taxes |
4.2 | (2.3)1 | 2.73 | (2.7)1 |
| and minorities | 4.1 | (2.0)1 | 1.43 | (4.2)1 |
| EBITDA | 5.9 | (1.1)1 | 8.83 | 2.31 |
2023 net profit EUR 1.4m vs EUR –4.2m in 2022
2) Includes Rest of the World (RoW).
1) Including other income 2022 of EUR 2.0 million (PPP forgiveness).
(EUR million, Unaudited)
(EUR million, Unaudited)
(EUR million, Unaudited)
• Expect improved gross margins and operational gearing
Market share in new markets +30%
Revenue growth 2021 - 2025 4x – 6x
Gross margin 40%
* Unaudited figures
| in EUR thousands | Q4 23 | Q4 22 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenues | 35 423 | 13 356 | 87 581 | 56 373 |
| Cost of sales | (22 842) | (9 188) | (56 964) | (37 911) |
| Gross Profit | 12 580 | 4 168 | 30 617 | 18 462 |
| Selling and distribution expenses | (869) | (1 024) | (2 661) | (3 437) |
| General and administrative expenses | (7 201) | (5 131) | (23 789) | (18 342) |
| Research and development expenses | (756) | (337) | (1 924) | (1 351) |
| Other income | 490 | 0 | 492 | 1 958 |
| Operating Results | 4 244 | (2 324) | 2 735 | (2 710) |
| Financial expense | (330) | 4 | (1 212) | (1 341) |
| Financial income | 40 | 76 | 84 | 97 |
| Net finance (cost) and or income | (290) | 80 | (1 128) | (1 244) |
| Results before tax | 3 954 | (2 244) | 1 606 | (3 954) |
| Income taxes | 143 | 275 | (186) | (224) |
| Net Results | 4 097 | (1 969) | 1 421 | (4 178) |
| Other comprehensive income | ||||
| Items that will be reclassified subsequently to profit and loss | ||||
| Exchange differences on translating foreign operations | (1 135) | (3 977) | (1 082) | 1 625 |
| Total other comprehensive income | (1 135) | (3 977) | (1 082) | 1 625 |
| Total comprehensive income | 2 962 | (5 946) | 339 | (2 553) |
| Profit attributable to: | ||||
| Owners of the parent | 4 094 | (1 967) | 1 418 | (4 182) |
| Non-controlling interests | 3 | (2) | 3 | 4 |
| Total Profit/(loss) for the period | 4 097 | (1 969) | 1 421 | (4 178) |
| Total comprehensive income attributable to: | ||||
| Owners of the parent | ||||
| Non-controlling interests | 2 960 | (5 944) | 337 | (2 556) |
| 3 | (2) | 3 | 4 | |
| 2 962 | (5 946) | 339 | (2 553) | |
| Number of weighted average (exclude treasury shares) shares used for calculations of EPS | ||||
| Earnings/(loss) per share for profit attributable to the ordinary equity holders of the parent during the period | 51 690 | 46 051 | 51 690 | 46 051 |
| - Basic (euro) |
0.08 | (0.04) | 0.03 | (0.09) |
| in EUR thousands | Note | 31.12.23 | 31.12.22 |
|---|---|---|---|
| Assets | |||
| Non-current assets | |||
| Intangible assets | 9 240 | 8 595 | |
| Property, plant and equipment | 17 503 | 14 175 | |
| Financial assets | 1 499 | 830 | |
| Deferred tax assets | 2 338 | 2 081 | |
| Restricted cash | - | - | |
| Total non-current assets | 30 580 | 25 681 | |
| Current assets | |||
| Inventory | 32 190 | 24 114 | |
| Trade and other receivables | 23 654 | 12 633 | |
| Cash and cash equivalents | 9 890 | 16 121 | |
| Restricted cash | - | 340 | |
| Total current assets | 65 733 | 53 208 | |
| Total assets | 96 314 | 78 889 |
| in EUR thousands | Note | 31.12.23 | 31.12.22 |
|---|---|---|---|
| Equity | |||
| Share capital | 2 585 | 2 303 | |
| Share premium | 71 022 | 56 939 | |
| Translation reserves | 4 510 | 5 591 | |
| Legal reserves | 7 725 | 7 575 | |
| Retained earnings | (43 092) | (44 511) | |
| Equity attributable to owners of the | 42 748 | 27 897 | |
| parent | |||
| Non-controlling interests | 45 | 43 | |
| Total equity | 42 794 | 27 940 | |
| Liabilities | |||
| Non-current liabilities | |||
| Borrowings | 9 312 | 10 930 | |
| Lease liabilities | 2 535 | 1 233 | |
| Other liabilities | 121 | 120 | |
| Deferred tax liability | 50 | 50 | |
| Total non-current liabilities | 12 018 | 12 333 | |
| Current liabilities | |||
| Borrowings | 7 363 | 3 620 | |
| Trade creditors | 15 850 | 10 055 | |
| Share lending liability | - | 15 000 | |
| Accrued expenses | 10 802 | 7 458 | |
| Provisions | 1 952 | 680 | |
| Lease liabilities | 1 058 | 620 | |
| Tax and social security | 4 478 | 1 182 | |
| Total current liabilities | 41 502 | 38 616 | |
| Total liabilities | 53 520 | 50 949 | |
| Total equity and liabilities | 96 314 | 78 889 |
| in EUR thousands | Note | FY 2023 | FY 2022 |
|---|---|---|---|
| Cashflow from operating activities | |||
| Operating results | 2 735 | (2 710) | |
| Adjustment for: | |||
| Depreciation & Amortization | 6 034 | 4 969 | |
| PPP loan forgiveness | - | (1 948) | |
| Changes in: | |||
| Changes in trade and other receivables | (12 268) | 807 | |
| Changes in inventories | (8 734) | (8 424) | |
| Changes in provisions | 1 283 | 499 | |
| Changes in trade and other payables | 12 644 | 5 572 | |
| Cash generated from operations | 1 693 | (1 236) | |
| Interest received and paid | (775) | (249) | |
| Income taxes paid | (366) | (278) | |
| Net cash flow from operating activities | 552 | (1 763) | |
| Investing activities | |||
| Development expenditure, patents | (2 112) | (2 462) | |
| Investments in property, plant & equipment | (6 014) | (5 944) | |
| Restricted cash (non -current) |
340 | - | |
| Net cash flow used in investing activities | (7 786) | (8 406) | |
| Financial activities | |||
| Proceeds of share issue | 14 514 | - | |
| Proceeds share lending | (15 000) | 15 000 | |
| Changes in borrowings – proceeds |
9 000 | 13 696 | |
| Changes in borrowings – repayments |
(6 440) | (4 779) | |
| Changes in lease liabilities | (1 088) | (648) | |
| Net cash flow from financing activities | 986 | 23 269 | |
| Net increase/(decrease) in cash and cash equivalents | (6 249) | 13 101 | |
| Opening position | 16 121 | 3 061 | |
| Foreign currency differences on | 17 | (41) | |
| cash and cash equivalents | |||
| Closing position | 9 890 | 16 121 | |
| The closing position consists of: | |||
| Cash and cash equivalents | 9 890 | 16 121 | |
| Total closing balance in cash and cash equivalents | 9 890 | 16 121 |
* Unaudited figures
[email protected] investorrelations@envipco.com
www.envipco.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.